共 50 条
Tip of the iceberg: A comprehensive review of liver disease in Inborn errors of immunity
被引:7
|作者:
Sharma, Disha
[1
,2
,3
]
Ben Yakov, Gil
[3
,4
]
Kapuria, Devika
[3
,5
]
Rodriguez, Gracia Viana
[3
]
Gewirtz, Meital
[3
]
Haddad, James
[3
]
Kleiner, David E.
[6
]
Koh, Christopher
[3
]
Bergerson, Jenna R. E.
[7
]
Freeman, Alexandra F.
[7
]
Heller, Theo
[3
]
机构:
[1] MedStar Washington Hosp Ctr, Dept Internal Med, Washington, DC USA
[2] Georgetown Univ, Washington, DC USA
[3] NIDDK, Liver Dis Branch, Translat Hepatol Sect, NIH, Bethesda, MD 20892 USA
[4] Sheba Med Ctr, Ctr Liver Dis, Tel Hashomer, Israel
[5] Univ New Mexico, Dept Gastroenterol, Albuquerque, NM 87131 USA
[6] NCI, Lab Pathol, Bethesda, MD 20892 USA
[7] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
来源:
关键词:
COMMON VARIABLE IMMUNODEFICIENCY;
CHRONIC GRANULOMATOUS-DISEASE;
NODULAR REGENERATIVE HYPERPLASIA;
X-LINKED AGAMMAGLOBULINEMIA;
STEM-CELL TRANSPLANTATION;
HEPATIC VENOOCCLUSIVE DISEASE;
WISKOTT-ALDRICH SYNDROME;
BONE-MARROW-TRANSPLANTATION;
CD40 LIGAND DEFICIENCY;
OF-FUNCTION MUTATIONS;
D O I:
10.1002/hep.32539
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Inborn errors of immunity (IEIs) consist of numerous rare, inherited defects of the immune system that affect about 500,000 people in the United States. As advancements in diagnosis through genetic testing and treatment with targeted immunotherapy and bone marrow transplant emerge, increasing numbers of patients survive into adulthood posing fresh clinical challenges. A large spectrum of hepatobiliary diseases now present in those with immunodeficiency diseases, leading to morbidity and mortality in this population. Awareness of these hepatobiliary diseases has lagged the improved management of the underlying disorders, leading to missed opportunities to improve clinical outcomes. This review article provides a detailed description of specific liver diseases occurring in various inborn errors of immunity. A generalized approach to diagnosis and management of hepatic complications is provided, and collaboration with hepatologists, immunologists, and pathologists is emphasized as a requirement for optimizing management and outcomes.
引用
收藏
页码:1845 / 1861
页数:17
相关论文